Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes (original) (raw)

References

1. Wiltshire S, Hattersley AT, Hitman GA, Walker M, Levy JC, Sampson M, O'Rahilly S, Frayling TM, Bell JI, Lathrop GM et al (2001) A genome wide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet 69:553–569
   Article CAS PubMed Google Scholar
2. Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL, Langefeld CD, Ally DS, Mohlke KL, Silander K, Kohtamaki K et al (2000) The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet 67:1174–1185
   CAS PubMed Google Scholar
3. Meigs JB, Panhuysen CI, Myers RH, Wilson PW, Cupples LA (2002) A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: the Framingham Offspring Study. Diabetes 51:833–840
   Article CAS PubMed Google Scholar
4. Groves CJ, Wiltshire S, Smedley D, Owen KR, Frayling TM, Walker M, Hitman GA, Levy JC, O'Rahilly S, Menzel S et al (2003) Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility. Diabetes 52:1300–1305
   Article CAS PubMed Google Scholar
5. Karamohamed S, Demissie S, Volcjak J, Liu C, Heard-Costa N, Liu J, Shoemaker CM, Panhuysen CI, Meigs JB, Wilson P et al (2003) NHLBI Framingham Heart Study: polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes 52:1562–1567
   Article CAS PubMed Google Scholar
6. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S et al (2007) Genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881–885
   Article CAS PubMed Google Scholar
7. Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 447:661–678
   Article Google Scholar
8. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JR, Rayner NW, Freathy RM et al (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336–1341
   Article CAS PubMed Google Scholar
9. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU et al (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341–1345
   Article CAS PubMed Google Scholar
10. Kwak SH, Cho YM, Moon MK, Kim JH, Park BL, Cheong HS, Shin HD, Jang HC, Kim SY, Lee HK et al (2008) Association of polymorphisms in the insulin-degrading enzyme gene with type 2 diabetes in the Korean population. Diabetes Res Clin Pract 79:284–290
    Article CAS PubMed Google Scholar
11. Hong MG, Reynolds C, Gatz M, Johansson B, Palmer JC, Gu HF, Blennow K, Kehoe PG, de Faire U, Pedersen NL et al (2008) Evidence that the gene encoding insulin degrading enzyme influences human lifespan. Hum Mol Genet 17:2370–2378
    Article CAS PubMed Google Scholar
12. Marlowe L, Peila R, Benke KS, Hardy J, White LR, Launer LJ, Myers A (2006) Insulin-degrading enzyme haplotypes affect insulin levels but not dementia risk. Neurodegener Dis 3:320–326
    Article CAS PubMed Google Scholar
13. Gu HF, Efendic S, Nordman S, Ostenson CG, Brismar K, Brookes AJ, Prince JA (2004) Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels. Diabetes 53:2137–2142
    Article CAS PubMed Google Scholar
14. Florez JC, Wiltshire S, Agapakis CM, Burtt NP, de Bakker PI, Almgren P, Bengtsson Boström K, Tuomi T, Gaudet D et al (2006) High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4, 206 people. Diabetes 55:128–135
    Article CAS PubMed Google Scholar
15. Duckworth WC, Bennett RG, Hamel FG (1998) Insulin degradation: progress and potential. Endocr Rev 19:608–624
    Article CAS PubMed Google Scholar
16. Fawcett J, Permana PA, Levy JL, Duckworth WC (2007) Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing. Arch Biochem Biophys 468:128–133
    Article CAS PubMed Google Scholar
17. Hamel FG, Bennett RG, Upward JL, Duckworth WC (2001) Insulin inhibits peroxisomal fatty acid oxidation in isolated rat hepatocytes. Endocrinology 142:2702–2706
    Article CAS PubMed Google Scholar
18. Kuo WL, Montag AG, Rosner MR (1993) Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rats tissues. Endocrinology 132:604–611
    Article CAS PubMed Google Scholar
19. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100:4162–4167
    Article CAS PubMed Google Scholar
20. Bennett RG, Hamel FG, Duckworth WC (2003) An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures. Diabetes 52:2315–2320
    Article CAS PubMed Google Scholar
21. Seta KA, Roth RA (1997) Overexpression of insulin degrading enzyme: cellular localization and effects on insulin signaling. Biochem Biophys Res Commun 231:167–171
    Article CAS PubMed Google Scholar
22. Boeing H, Korfmann A, Bergmann MM (1999) Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Ann Nutr Metab 43:205–215
    Article CAS PubMed Google Scholar
23. Bergmann MM, Bussas U, Boeing H (1999) Follow-up procedures in EPIC-Germany—data quality aspects. European Prospective Investigation into Cancer and Nutrition. Ann Nutr Metab 43:225–234
    Article CAS PubMed Google Scholar
24. Schulze MB, Al-Hasani H, Boeing H, Fisher E, Döring F, Joost HG (2007) Variation in the HHEX-IDE gene region predisposes to type 2 diabetes in the prospective, population-based EPIC-Potsdam cohort. Diabetologia 50:2405–2407
    Article CAS PubMed Google Scholar
25. Schulze MB, Hoffmann K, Boeing H, Linseisen J, Rohrmann S, Möhlig M, Pfeiffer AF, Spranger J, Thamer C, Häring HU et al (2007) An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 30:510–515
    Article PubMed Google Scholar
26. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Renn W, Gerich J (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295–301
    Article CAS PubMed Google Scholar
27. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470
    Article CAS PubMed Google Scholar
28. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53:79–91
    Article PubMed Google Scholar
29. Barlow WE, Ichikawa L, Rosner D, Izumi S (1999) Analysis of case-cohort designs. J Clin Epidemiol 52:1165–1172
    Article CAS PubMed Google Scholar
30. Nyholt DR (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765–769
    Article CAS PubMed Google Scholar
31. Rudovich NN, Rochlitz HJ, Pfeiffer AFHP (2004) Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients. Diabetes 53:2359–2365
    Article CAS PubMed Google Scholar
32. Ahuja N, Schwer B, Carobbio S, Waltregny D, North BJ, Castronovo V, Maechler P, Verdin E (2007) Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J Biol Chem 282:33583–33592
    Article CAS PubMed Google Scholar
33. Pivovarova O, Nikiforova VJ, Pfeiffer AFHP, Rudovich N (2008) The influence of genetic variations in HHEX gene on insulin metabolism in the German MESYBEPO cohort. Diabetes Metab Res Rev 25:156–162
    Article Google Scholar
34. Staiger H, Stancáková A, Zilinskaite J, Vänttinen M, Hansen T, Marini MA, Hammarstedt A, Jansson PA, Sesti G, Smith U et al (2008) A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study. Diabetes 57:514–517
    Article CAS PubMed Google Scholar

Download references